IRSB Financials 07/16/2014 18:19:02 Iris Biotechn

IRSB Financials 07/16/2014 18:19:02
Iris Biotechnologies, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development 59 130 217 477
Sales, General and Admin. 417 440 416 613
Non-Recurring Items - - - -
Other 5 14 16 17
Operating Income (481) (584) (650) (1,107)
Income From Continuing Operations
Add'l Income/Expense Items - - 197 35
Earnings Before Interest and Tax (486) (586) (473) (1,082)
Interest Expense - - - -
Earnings Before Tax (486) (586) (473) (1,082)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (486) (586) (473) (1,082)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (486) (586) (473) (1,082)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (486) (586) (473) (1,082)